<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 9.2: Crohnâ€™s Disease: Deep Dive into IBD Pathogenesis</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE/TEAL theme for Autoimmune */
        .module-header {
            background: linear-gradient(135deg, #0f172a 0%, #1e293b 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e293b;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e293b;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e293b;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f8fafc;
            border: 2px solid #334155;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #334155;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f1f5f9 0%, #e2e8f0 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #cbd5e1;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #334155;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #334155;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e293b;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e293b;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #e2e8f0;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #1e293b;
            font-weight: 600;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e293b 0%, #334155 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #334155, #1e293b);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e293b 0%, #334155 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
        }

        /* Data Tables */
        .data-table-container {
            margin: 30px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            color: #1e293b;
            font-weight: 600;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e293b;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            margin-top: 14px;
            padding: 14px;
            background: #f0f8f0;
            border-radius: 8px;
            color: #166534;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 25px;
            margin-top: 35px;
            border-radius: 12px;
            border: 1px solid #cbd5e1;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border-top: 1px solid #eee;
            font-size: 14px;
        }

        .references-box h4 {
            margin-bottom: 15px;
            color: #1e293b;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 10px;
            color: #666;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .stats-grid { grid-template-columns: repeat(2, 1fr); }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 9: Gastrointestinal & Hepatic Autoimmunity</p>
            <h1 class="lesson-title">Lesson 9.2: Crohnâ€™s Disease: Deep Dive into IBD Pathogenesis</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <!-- Table of Contents -->
        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Pathophysiology & Transmurality</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Genetic Architecture: The NOD2 Axis</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Antigen Mapping: Microbial Triggers</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Regulatory Modulation: Th1/Th17 Dominance</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Mucosal Integrity & Autophagy</a></li>
                <li><a href="#section6"><span class="section-num">6</span>The A.R.M.O.R. Clinical Framework</a></li>
            </ul>
        </div>

        <!-- Learning Objectives -->
        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate Crohnâ€™s Disease from Ulcerative Colitis based on anatomical and histological features.</li>
                <li>Analyze the role of <span class="highlight">NOD2 mutations</span> and defective autophagy in the failure of innate immune surveillance.</li>
                <li>Identify key microbial antigens (AIEC, MAP) and their role in molecular mimicry.</li>
                <li>Apply the A.R.M.O.R. Methodâ„¢ to design a targeted intervention for Crohn's remission maintenance.</li>
                <li>Evaluate the impact of oxidative stress on mitochondrial health in the intestinal epithelium.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Complexity of Crohn's Disease</h3>
            <p>Unlike many autoimmune conditions that target a specific organ with surgical precision, Crohn's Disease (CD) represents a profound systemic breakdown of the relationship between the host, the microbiome, and the environment. It is a <span class="highlight">transmural</span> inflammatory process, meaning it penetrates the full thickness of the bowel wall, leading to complications rarely seen in other IBD forms, such as fistulas and strictures. In this lesson, we move beyond "gut inflammation" to explore the molecular failure of tolerance.</p>
        </div>

        <!-- Key Terms -->
        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Transmural Inflammation</p>
                    <p class="definition">Inflammation affecting all layers of the intestinal wall (mucosa, submucosa, muscularis, and serosa).</p>
                </div>
                <div class="term-item">
                    <p class="term">Skip Lesions</p>
                    <p class="definition">Segments of diseased bowel separated by segments of healthy-appearing bowel, a hallmark of Crohn's.</p>
                </div>
                <div class="term-item">
                    <p class="term">Autophagy</p>
                    <p class="definition">The cellular "recycling" process; defects in this pathway (ATG16L1 gene) prevent the clearance of intracellular pathogens.</p>
                </div>
                <div class="term-item">
                    <p class="term">Fistula</p>
                    <p class="definition">An abnormal connection or tunnel between two organs or between an organ and the skin, often resulting from deep ulceration.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">1. Pathophysiology & Transmurality</h2>
        <p>Crohn's Disease is characterized by a "patchy" distribution that can affect any part of the gastrointestinal tract, from the mouth to the anus. However, it shows a strong preference for the <span class="highlight">terminal ileum</span> (the end of the small intestine) and the proximal colon. A 2022 meta-analysis confirmed that approximately 70% of patients present with ileocolic involvement.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Crohnâ€™s Disease (CD)</th>
                        <th>Ulcerative Colitis (UC)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Location</strong></td>
                        <td>Anywhere in GI tract (Mouth to Anus)</td>
                        <td>Limited to Colon and Rectum</td>
                    </tr>
                    <tr>
                        <td><strong>Pattern</strong></td>
                        <td>Skip Lesions (Patchy)</td>
                        <td>Continuous Inflammation</td>
                    </tr>
                    <tr>
                        <td><strong>Depth</strong></td>
                        <td>Transmural (All layers)</td>
                        <td>Mucosal (Surface layer)</td>
                    </tr>
                    <tr>
                        <td><strong>Granulomas</strong></td>
                        <td>Present in ~30% of biopsies</td>
                        <td>Absent</td>
                    </tr>
                    <tr>
                        <td><strong>Complications</strong></td>
                        <td>Fistulas, Strictures, Malabsorption</td>
                        <td>Toxic Megacolon, Malignancy Risk</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>The transmural nature of CD leads to the "cobblestone" appearance seen during endoscopy. Deep longitudinal and transverse ulcers create islands of bulging, edematous mucosa. Because the inflammation reaches the serosa (outer layer), the bowel can become "sticky," leading to adhesions and the characteristic <span class="highlight">creeping fat</span> (mesenteric fat wrapping around the bowel), which is now recognized as a bioactive tissue contributing to the inflammatory cytokine pool.</p>

        <h2 id="section2">2. Genetic Architecture: The NOD2 Axis</h2>
        <p>The genetic basis of Crohn's is among the strongest in the autoimmune field. The discovery of the <span class="highlight">NOD2 (Nucleotide-binding Oligomerization Domain-containing protein 2)</span> gene on chromosome 16 was a watershed moment. NOD2 acts as an intracellular "sensor" for bacterial cell wall components (muramyl dipeptide).</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">20-40x</div>
                    <div class="stat-label">Risk increase with 2 NOD2 mutations</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">200+</div>
                    <div class="stat-label">Genetic loci linked to CD</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">50%</div>
                    <div class="stat-label">Concordance in Identical Twins</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">15%</div>
                    <div class="stat-label">Patients with family history</div>
                </div>
            </div>
        </div>

        <p>When NOD2 is mutated, the innate immune system fails to recognize and clear commensal bacteria effectively. This paradoxically leads to an *overcompensation* by the adaptive immune system, resulting in chronic, uncontrolled inflammation. Essentially, the "first responders" (innate immunity) fail to show up, so the "heavy artillery" (adaptive immunity) is called in, causing massive collateral tissue damage.</p>

        <h2 id="section3">3. Antigen Mapping: Microbial Triggers</h2>
        <p>Under the A.R.M.O.R. Methodâ„¢, <span class="highlight">Antigen Mapping (A)</span> focuses on identifying the specific triggers that initiate the flare. In Crohn's, the primary antigens are often microbial. Two specific pathogens have gained significant research traction:</p>

        <ul>
            <li><strong>Adherent-Invasive E. coli (AIEC):</strong> These bacteria are found in 30-50% of CD patients compared to <5% of healthy controls. They have the unique ability to survive inside macrophages and adhere strongly to ileal enterocytes.</li>
            <li><strong>Mycobacterium avium paratuberculosis (MAP):</strong> While controversial, some researchers argue CD is a form of "slow infection" similar to Johne's disease in cattle. MAP has been detected in a significant percentage of CD tissue samples.</li>
        </ul>

        <div class="alert-box info">
            <p class="alert-label">Practitioner Insight: Molecular Mimicry</p>
            <p>Antigen mapping in CD should also include dietary proteins. In a damaged gut, proteins like yeast (Saccharomyces cerevisiae) can trigger the production of <span class="highlight">ASCA (Anti-Saccharomyces cerevisiae antibodies)</span>. Elevated ASCA levels are 95% specific for Crohn's and often correlate with a more aggressive disease course.</p>
        </div>

        <!-- Case Study 1 -->
        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The Failed Surveillance</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Antigen Mapping & Mucosal Repair</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah J., Age 29</h4>
                        <p>Presenting: Terminal ileitis, chronic diarrhea (6-8x daily), weight loss (15 lbs), and perianal pain.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Utilizing the A.R.M.O.R. Method, Sarah's team mapped her triggers (Antigen Mapping), identifying high ASCA levels and AIEC presence. We implemented a <span class="highlight">Specific Carbohydrate Diet (SCD)</span> to starve AIEC, combined with high-dose Vitamin D (5,000 IU/day) for <strong>Regulatory Modulation</strong> to support Treg cells.</p>
                <p><strong>Outcomes:</strong> After 4 months, Sarahâ€™s fecal calprotectin dropped from 840 Î¼g/g to 110 Î¼g/g. Her bowel movements stabilized to 1-2 daily, and she regained 10 lbs. Follow-up imaging showed significant reduction in ileal wall thickening.</p>
            </div>
        </div>

        <h2 id="section4">4. Regulatory Modulation: Th1/Th17 Dominance</h2>
        <p>The immunological signature of Crohn's is a distinct shift toward <span class="highlight">Th1 and Th17 pathways</span>. This is driven by the overproduction of cytokines like IL-12, IL-23, and TNF-alpha. TNF-alpha, in particular, acts as a master regulator, increasing the permeability of the gut lining and inducing apoptosis in epithelial cells.</p>

        <p>Regulatory Modulation (R) aims to restore the balance between these pro-inflammatory cells and the anti-inflammatory T-regulatory (Treg) cells. In CD, Treg cells are often present in the tissue but are "exhausted" or rendered ineffective by the high-TNF environment. Interventions such as <span class="highlight">Curcumin (BCM-95)</span> and <span class="highlight">Resveratrol</span> have been shown in clinical trials to inhibit the NF-kB pathway, effectively dampening the Th17 response.</p>

        <h2 id="section5">5. Mucosal Integrity & Autophagy</h2>
        <p>In Lesson 1, we discussed the "leaky gut" in Celiac disease. In Crohn's, the barrier failure is even more profound due to <span class="highlight">defective autophagy</span>. Autophagy is the process by which cells "clean up" debris and intracellular bacteria. If the ATG16L1 or IRGM genes are mutated, the intestinal cells cannot clear out invading pathogens like AIEC.</p>

        <p>This failure of <strong>Mucosal Integrity (M)</strong> leads to:
            <ul class="content-list">
                <li><strong>LPS Translocation:</strong> Lipopolysaccharides from gram-negative bacteria enter the systemic circulation, triggering widespread inflammation.</li>
                <li><strong>Mitochondrial Dysfunction:</strong> The intestinal cells (enterocytes) lose their ability to produce ATP efficiently, leading to cell death and ulceration.</li>
                <li><strong>Dysbiosis:</strong> A marked reduction in *Faecalibacterium prausnitzii*, a keystone species that produces butyrate, which is the primary fuel for colonocytes.</li>
            </ul>
        </p>

        <h2 id="section6">6. The A.R.M.O.R. Clinical Framework</h2>
        <p>To achieve long-term remission in Crohnâ€™s, the practitioner must address all five pillars of the A.R.M.O.R. Methodâ„¢:</p>

        <div class="principle-card">
            <p class="principle-title">A - Antigen Mapping</p>
            <p class="principle-text">Identify microbial triggers (AIEC, MAP) and dietary triggers (yeast, emulsifiers like carboxymethylcellulose). Use ASCA and fecal calprotectin for monitoring.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">R - Regulatory Modulation</p>
            <p class="principle-text">Support Treg cells using Vitamin D, Omega-3 fatty acids (EPA/DHA), and potentially low-dose naltrexone (LDN) to modulate the opioid-growth factor axis.</p>
        </div>

        <div class="principle-card" style="border-left-color: #B8860B;">
            <p class="principle-title">M - Mucosal Integrity</p>
            <p class="principle-text">Repair the barrier with L-Glutamine, Zinc Carnosine, and butyrate-producing fibers (if tolerated) or oral butyrate supplements.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">O - Oxidative Stress Mitigation</p>
            <p class="principle-text">Neutralize ROS with targeted antioxidants like EGCG (from green tea) and N-Acetyl Cysteine (NAC) to protect mitochondrial function in enterocytes.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">R - Remission Maintenance</p>
            <p class="principle-text">Establish a "Safe Harbor" diet (e.g., modified Mediterranean or SCD) and implement stress-reduction techniques to manage the gut-brain axis.</p>
        </div>

        <!-- Check Your Understanding -->
        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of Crohn's pathogenesis</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why are "skip lesions" a significant diagnostic indicator for Crohn's Disease versus Ulcerative Colitis?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Skip lesions indicate patchy, non-continuous inflammation that can occur anywhere in the GI tract, which is a hallmark of Crohn's. In contrast, Ulcerative Colitis presents with continuous inflammation starting from the rectum and moving proximally.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Explain the "Innate Immune Paradox" involving the NOD2 gene in Crohn's Disease.</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The paradox is that a *deficiency* in innate immune sensing (caused by NOD2 mutations) leads to an *overactive* adaptive immune response. Because the body fails to clear bacteria initially, it triggers a massive, chronic Th1/Th17 inflammatory cascade to compensate.</div>
            </div>
        </div>

        <!-- Takeaways -->
        <div class="takeaways-box">
            <p class="box-label">Key Lesson Takeaways</p>
            <ul>
                <li>Crohnâ€™s is a transmural, granulomatous disease that can affect the entire GI tract but favors the terminal ileum.</li>
                <li>Genetic mutations in NOD2 and ATG16L1 (autophagy) create a fertile ground for immune surveillance failure.</li>
                <li>Microbial antigens like AIEC and MAP are key triggers that must be addressed in the "Antigen Mapping" phase.</li>
                <li>A.R.M.O.R. Methodâ„¢ application focuses on shifting the Th1/Th17 dominance toward a Treg-mediated tolerance.</li>
                <li>Transmural inflammation leads to unique complications like fistulas and strictures, requiring aggressive mucosal repair.</li>
            </ul>
        </div>

        <!-- References -->
        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Torres et al. (2020). "Crohn's disease." The Lancet.</li>
                <li>Rizzello et al. (2021). "The role of NOD2 in IBD: From genetics to the clinic." Journal of Clinical Medicine.</li>
                <li>Glassner et al. (2022). "The gut microbiome in inflammatory bowel disease: current concepts and future directions." Nature Reviews Gastroenterology & Hepatology.</li>
                <li>Sartor et al. (2021). "Therapeutic manipulation of the enteric microbiota in inflammatory bowel diseases." Gastroenterology.</li>
                <li>Nishida et al. (2023). "Oxidative stress and inflammatory bowel disease: A review of the role of antioxidants." World Journal of Gastroenterology.</li>
                <li>Graham et al. (2022). "Mycobacterium avium paratuberculosis and Crohn's disease: A review of the evidence." Frontiers in Medicine.</li>
            </ul>
        </div>

        <div class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </div>
    </div>
</body>

</html>